Clinical information for control, AD, and FTLD-TDP subjects
| Pathological diagnosis | Age at death | Gender | PMI | Other findings |
|---|---|---|---|---|
| Control | ||||
| 1 | 86 | F | 7.8 | — |
| 2 | 76 | M | 8.2 | — |
| AD | — | |||
| 1 | 63 | M | 6.0 | — |
| 2 | 62 | M | 9.9 | — |
| 3 | 72 | M | 7.9 | — |
| FTLD-TDP-A | ||||
| 1 | 64 | M | 2.3 | AGD |
| 2 | 72 | M | 23.8 | — |
| 3 | 78 | F | 9.0 | — |
The pathological diagnosis, age at death, gender, post-mortem interval (PMI), and secondary pathological findings for all subjects in Figure 8 are listed. All subjects were negative for Pgrn mutations. AGD, Argyrophilic grain disease.